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Background: Formation of a mature core is a crucial event for infectivity of retroviruses such as Mason-Pfizer monkey
virus (M-PMV). The process is triggered by proteolytic cleavage of the polyprotein precursor Gag, which releases matrix,
capsid (CA), and nucleocapsid proteins. Once released, CA assembles to form a mature core – a hexameric lattice
protein shell that protects retroviral genomic RNA. Subtle conformational changes within CA induce the transition from
the immature lattice to the mature lattice. Upon release from the precursor, the initially unstructured N-terminus of CA
is refolded to form a β-hairpin stabilized by a salt bridge between the N-terminal proline and conserved aspartate.
Although the crucial role of the β-hairpin in the mature core assembly has been confirmed, its precise structural
function remains poorly understood.
Results: Based on a previous NMR analysis of the N-terminal part of M-PMV CA, which suggested the role of
additional interactions besides the proline-aspartate salt bridge in stabilization of the β-hairpin, we introduced a
series of mutations into the CA sequence. The effect of the mutations on virus assembly and infectivity was analyzed.
In addition, the structural consequences of selected mutations were determined by NMR spectroscopy. We identified a
network of interactions critical for proper formation of the M-PMV core. This network involves residue R14, located in
the N-terminal β-hairpin; residue W52 in the loop connecting helices 2 and 3; and residues Q113, Q115, and Y116 in
helix 5.
Conclusion: Combining functional and structural analyses, we identified a network of supportive interactions that
stabilize the β-hairpin in mature M-PMV CA.
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Formation of a mature, fully infectious retroviral particle
encompasses two distinct steps: (i) assembly of an im-
mature, roughly spherical particle from Gag-derived
polyprotein precursors and (ii) proteolytic cleavage of
the polyprotein precursors, leading to reorganization
of the immature particle interior and formation of a
mature core.* Correspondence: rumlova@uochb.cas.cz
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unless otherwise stated.The immature particle of a retrovirus such as Mason-
Pfizer monkey virus (M-PMV) consists of approximately
1500–2500 Gag molecules that are self-associated into a
hexameric lattice. Maturation of the immature particle
takes place during or shortly after budding through the
host cell membrane. The viral protease is autocatalytically
activated and cleaves Gag into the individual structural
proteins matrix (MA), capsid (CA), and nucleocapsid
(NC). Proteolytic cleavage initiates changes in the CA
structure, enabling subsequent formation of a mature
hexameric lattice that forms the viral core. Because the
mature CA shell protects the viral genomic RNA, proper
rearrangement of CA allowing correct assembly of CA
proteins is crucial for the viral life cycle.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the N-terminal domain (NTD) and C-terminal domain
(CTD), connected by a short flexible segment. Despite
low sequence homology among CAs from different retro-
viruses, the structural arrangement of both CA domains
is highly conserved [1-7]. The NTD consists of an N-
terminal β-hairpin followed by six or seven α-helices,
and the CTD consists of four α-helices. Interactions
between CA domains, i.e., NTD-NTD, CTD-CTD, and
NTD-CTD, are crucial for assembly. Interestingly, the
structural roles of the two domains are exchanged in the
immature and mature hexameric lattices. While immature
intra-hexameric contacts are formed predominantly by
CTD-CTD interactions, the mature hexameric unit is held
together by NTD-NTD interactions [8,9].
The NMR structure of the N-terminal 283-amino-acid
fragment of HIV-1 Gag, comprising MA and CA-NTD,
confirmed the hypothesis that the region corresponding
to the β-hairpin is unfolded in the Gag polyprotein and
that β-hairpin formation is triggered upon complete
proteolytic cleavage and release of CA from Gag [10].
Comparing the structures of mature HIV-1 CA-NTD
and HIV-1 CA-NTD N-terminally extended to MA
revealed that β-hairpin formation induces negligible
structural changes, including a small displacement of
helix 6 (residues 112–117 in HIV-1 CA) [10,11]. One of
the initially suggested roles of the β-hairpin was formation
of a β-barrel-like structure stabilizing mature hexamers.
However, the electron cryo-crystallography map of HIV-1
CA showed that the individual strands are too far separated
to mediate direct interactions stabilizing the mature CA
hexamer [12]. Currently, it is assumed that the β-hairpin
plays a role in destabilization of the immature lattice and
formation of CA interfaces, mediating the crucial interac-
tions for stabilization of the mature lattice [10-14].
The length of the N-terminal β-hairpins varies slightly
in different retroviruses. However, this structural motif
is invariably stabilized by a salt bridge between the N-
terminal proline and an aspartate or glutamate residue
in helix 3 [1,2,5,6,15]. In M-PMV, the β-hairpin is stabi-
lized by a salt bridge between the N-terminal proline
(P1) and D57 [6]. Mutating these two residues in a proviral
M-PMV DNA resulted in altered M-PMV Gag processing,
and the mutated viral particles released from the trans-
fected cells had aberrant cores and were non-infectious
[16]. Similarly, any modifications of M-PMV CANC, a
Gag-derived protein that mimics the assembly of mature
particles, affecting β-hairpin formation (e.g., deletion
[ΔProCANC], mutation of P1 or D57, or N-terminal
extension of CA by one or more amino acids) resulted
in the inability of CANC to form mature-like tubular
structures in an in vitro assembly assay. Instead, immature-
like, spherical virus-like particles (VLPs) were formed
[16,17]. The situation is different in the case of HIV-1ΔProCANC. Even though deletion of the N-terminal
proline should prevent β-hairpin formation, HIV-1
ΔProCANC is still able to assemble into tubular,
mature-like particles [18]. In contrast, deletion of the
N-terminal proline in the Rous sarcoma virus (RSV)
CANC protein (ΔProCANC) resulted in an inability to
assemble into any regular structure [19]. Both HIV-1
and RSV require N-terminal extensions to CA to initiate
assembly of immature-like particles [19-21].
Based on the NMR structure of M-PMV CA-NTD, we
previously identified residues other than P1 and D57 that
are potentially important in stabilization of the β-hairpin
relative to the α-helical core [6]. These residues comprise
R14 and H16 in the β-hairpin and D111 and D117 in
helix 5.
In our present work, we studied the necessity of
additional β-hairpin stabilization for mature particle
formation. Mutations in the β-hairpin and helix 5 of
CA-NTD were introduced into the M-PMV sequence,
and their impact on the assembly of mature particles
was investigated. Both in vitro and in vivo experiments
confirmed the critical role of residue R14 in the β-hairpin,
W52 located in the loop connecting helices 2 and 3, and
residues Q113, Q115, and Y116 in helix 5. Comparing
the chemical shifts in NMR spectra of R14K and WT
CA-NTD showed that the mutation caused changes
only in the vicinity of helix 5. Mutation of R14 as well as
mutation of residues in helix 5 resulted in aberrant
cleavage of CA during M-PMV maturation. Comparison
of hydrogen-deuterium exchange of R14K and WT CA-
NTD showed that the R14K mutation leads to an increase




The NMR structure of M-PMV CA-NTD is composed
of six α-helices and an N-terminal β-hairpin [6]. The
N-terminal β-hairpin is stabilized by a salt bridge
between P1 and D57 in helix 3. Besides the salt bridge,
most residues involved in the stabilization of the β-hairpin
lie in helix 5 [6].
To analyze the importance of helix 5 in stabilization of
the β-hairpin, we prepared a mutant, termed A4Hel5, in
which four helix 5 residues (D111, Q113, M114, Q115)
were replaced with alanines (Figure 1). Due to the spatial
proximity of residue R14 in the β-hairpin and D111 in
helix 5, an electrostatic interaction between these two
residues was proposed to additionally stabilize the β-hairpin
[6]. To analyze the importance of this putative interaction,
we prepared a series of mutations, exchanging both resi-
dues for small neutral, isopolar and oppositely charged
residues (i.e., R14A, R14K, R14E and D111A, D111E,
D111N) (Figure 1). All mutations were introduced into
Figure 1 Schematic representation of M-PMV CA-NTD. Amino acid sequences of M-PMV CA-NTD wild type (WT) and mutants (R14A, R14E,
R14K, D111A, D111E, D111N, A4Hel5) used in this study. The positions of secondary structure elements are annotated above the sequence.
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(CANCpET22b), the proteins were expressed in E. coli
BL21 (DE3) (Figure 2), and transmission electron micros-
copy (TEM) analysis of bacterial thin-sections was carried
out (Figure 2). The M-PMV CANC and ΔProCANC pro-
teins have previously been shown to assemble into tubular,
mature-like particles or roughly spherical, immature-like
particles, respectively [17,18,22]. TEM analysis of bacterial
cells expressing the mutant CANC proteins revealed three
different phenotypes: D111A and D111E formed WT-like
tubular structures similar to those observed for mature-
like CANC; D111N and A4Hel5 failed to assemble into
any regular structure; and R14A, R14K, and R14E as-
sembled into particles of spherical appearance similar to
those observed for immature-like ΔProCANC particles.
These data suggest that residues 110–115 in helix 5 play
an important role in assembly.
M-PMV particle production, release, processing,
morphology, and infectivity
Next, we studied the impact of the mutations on the
M-PMV life cycle. The mutations were introduced into
a proviral M-PMV vector (pSARM4). To analyze the effect
of the mutations on expression and release of viral parti-
cles, HEK 293 T cells were transiently transfected with the
WT and mutant proviral vectors, and expression of poly-
protein precursors and virus release were evaluated in
pulse-chase experiments. At 48 h post-transfection, the
proteins were metabolically labeled with 35S and chased
for 4 h. Viral particles released into the cultivation media
were collected by centrifugation through a sucrose cush-
ion. Both intracellular proteins and those released into the
medium were immunoprecipitated with an anti-M-PMV
CA antibody. Gag, Gag-Pro, and Gag-Pro-Pol polyprotein
precursors were detected in all samples (Figure 3A).Mature CA protein was present in viral particles released
from cells expressing the WT protein and the D111
mutants (D111A, D111N, and D111E; Figure 3B, C). In
addition to properly processed CA, an internal cleav-
age product with a molecular weight of approximately
20 kDa (p20CA) was detected in virions released from
cells expressing A4Hel5 or R14 mutants (R14A, R14K,
and R14E; Figure 3C). No significant block of virus re-
lease, calculated from relative cell- and virion-associated
protein levels, was observed for any of the mutants
(Figure 3D). To confirm impaired maturation, Western
blot analysis of pelleted viral particles released from cells
transfected with the mutants was performed (Figure 3E).
Indeed, in contrast to the WT and D111 mutants, in
which we detected only properly processed CA, we ob-
served inefficient Gag processing in A4Hel5 and R14
mutants, resulting in CA containing proteins of higher
molecular weight (Figure 3E). Moreover, the internal
cleavage product p20CA was observed in the A4Hel5
and R14 mutants (Figure 3E). By performing Edman
degradation of p20CA, we identified this newly created
cleavage site as 39PYTLA*IVESV48, located within helix 2
of the CA protein (Figure 3F). The 20-kDa product result-
ing from internal CA cleavage thus corresponds to the
fragment 44IVESV-GLAM226.
To analyze the effect of D111, R14, and A4Hel5 muta-
tions on formation of immature and mature M-PMV
particles, HEK 293 T cells were transiently transfected
with WT and mutant proviral vectors. The cells were
fixed, and ultrathin sections of the cells were analyzed
using TEM (Figure 4). Similar to WT, all the mutants as-
sembled their immature particles within the cytoplasm
of the cells. The only exception was the A4Hel5 mutant,
which did not assemble typical intracytoplasmic particles.
Instead, only C-type-like particles accumulated underneath
Figure 2 Expression and morphology of mutant M-PMV CANC in E.coli. Coomassie blue stained SDS-PAGE gel of E. coli expressing WT and mutant
M-PMV CANC proteins (upper left panel). Electron micrographs of thin sections of E. coli expressing WT and mutant M-PMV CANC. Bars: 200 or 500 nm.
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cles, cores resembling those formed by WT were observed
for the D111 mutants. In contrast, aberrant core-like
structures were found in released A4Hel5 and R14 mutant
virions (Figure 4B).
Next, we analyzed the effect of the D111, R14, and
A4Hel5 mutations on M-PMV infectivity in a single-
round infectivity assay [23]. The mutations were intro-
duced into the pSARM-EGFP vector, which carries the
entire M-PMV genome except for the env gene, which is
replaced with EGFP. This plasmid was co-transfected
with an Env-expression vector (pTMO) [24] into HEK
293 T cells. Virions released into cell culture supernatantswere normalized for CA content and used for infection of
fresh HEK 293 T cells. At 48 h post-infection, the cells
were analyzed by flow cytometry (Figure 5). The relative
infectivity of the WT was considered 100%. Except for the
D111E mutant, whose infectivity decreased by approxi-
mately 30% compared to WT, the other D111 mutations
had no effect on M-PMV infectivity. In contrast, A4Hel4
and all three R14 mutants were completely noninfectious.
Structural analysis of D111N and R14K CA-NTD
To assess the importance of residues R14 and D111 in
stabilization of the β-hairpin, we performed NMR struc-
tural analysis of D111N and R14K CA-NTD mutants.
Figure 3 (See legend on next page.)
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Figure 3 Synthesis, release, and processing of WT and mutant M-PMV CA-NTD. HEK 293 T cells were transfected with WT or mutant M-PMV
CA-NTD proviral DNA. Viral proteins were metabolically labeled with a [35S] cysteine-methionine mix for 30 min and chased for 16 h. M-PMV
CA-related proteins were then immunoprecipitated from the cells and culture media and analyzed by SDS-PAGE: (A) Intracellular M-PMV proteins
Gag (Pr78), Gag-Pro (Pr95), and Gag-Pro-Pol (Pr180) immunoprecipitated from cell lysate after 30 min pulse, and (B) after 16 h chase. (C) CA-derived
proteins of released M-PMV particles were immunoprecipitated from the culture media 16 h after the chase. (D) Quantification of WT and mutant
M-PMV particle release from HEK 293 T cells. Band intensities of [35S] pulse–labeled Gag (Pr78) and released CA were calculated. The relative percent of
CA released into the culture media was corrected for intracellular expression of individual samples. (E) Western blot analysis of released WT and mutant
M-PMV CA-NTD particles. VLPs from the culture media were collected by centrifugation through a 20% sucrose cushion 48 h post-transfection. The viral
proteins were analyzed by SDS-PAGE, blotted onto a nitrocellulose membrane, and detected with rabbit antibodies raised against M-PMV CA.
(F) Amino acid sequence of 80 N-terminal amino acids of M-PMV CA. The arrow indicates the internal cleavage between A43 and I44 identified by
N-terminal amino acid sequencing.
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NTD expression vector (CA-NTDpET22b), and the
corresponding 13C and 15N double-labeled proteins
were expressed in E. coli BL21 (DE3) cells. The proteins
were purified by gel chromatography and concentrated to
2 mM. The 1H-15N HSQC spectra of both proteins were
well-dispersed, with the majority of cross-peaks superim-
posable on the WT spectrum, confirming that both pro-
teins were properly folded and that their overall folds did
not differ from that of WT. To assign chemical shifts of
the backbone amide group atoms, three triple-resonance
experiments (HNCA, HNCACB, CBCA(CO)NH) and
HCCH-TOCSY were conducted (Additional file 1:
Figure S1). For the D111N mutant, 125 backbone amide
resonances of 135 possible were assigned, and for the
R14K mutant, 119 resonances were assigned. Residues
that were not assigned in the WT CA-NTD (i.e., G8, Y40,
G68, G69, N106, and T110) [6] could not be assigned in
the spectra of the mutant proteins either. In addition to
those, the following residues were not assigned in the
D111N mutant: T37, G93, G95, and N111; and in the
R14K mutant: V2, W13, K14, H15, H16, N17, G18, F19,
D20, and F21. The increased number of missing reso-
nances in the N-terminus of R14K mutant is probably
caused by β-hairpin impairment and slow conformational
exchange. This strengthens our model of increased β-
hairpin flexibility in the R14K mutant. Because the chem-
ical shifts of the backbone amides of D111N CA-NTD
were very similar to those of WT (Figure 6A, red), we
measured the 15N-edited NOESY spectrum of the mutant
and compared it with the WT spectrum. Long range NOE
contacts of close neighbors of N111 and residues from the
β-hairpin showed no difference compared with the corre-
sponding contacts in WT (data not shown). Based on
these data, we concluded that the effect of the D111N mu-
tation on the structure of CA-NTD is negligible.
Comparison of the available amide combined chemical
shifts (CCS) of R14K CA-NTD to those of WT revealed
that the mutation had an effect on the chemical environ-
ment of 14 residues (Figure 6A, blue). These residues
are localized in or close to helix 5 (Q113, M114, Q115,
Y116, D117, G119, F121, A122), in the β-hairpin (T3,E4, T5, V6), and in the proximity of helix 3 (W52, D57).
Interestingly, the residues affected by the R14K mutation
are closely clustered in the CA-NTD domain (Figure 6B).
To analyze whether these residues participate in β-hairpin
stabilization, several of them (i.e., E4 in the β-hairpin;
W52 in the loop connecting helix 2 and 3; and M114,
Q115, and Y116 in helix 5; and additionally, H16 residue
selected on the basis of its proximity to the aforemen-
tioned residues in the NMR structure of the WT CA-
NTD) were mutated to alanine. We determined the
impact of these mutations on M-PMV CA processing
and infectivity of the virus (Figure 6 C,D). An internal
cleavage of CA, similar to that detected in the R14 and
A4Hel5 mutants, was observed in the E4A, H16A, W52A,
Q115A, Q115E, and Y116A mutants, but not in M114A
(Figure 6C). Decreased infectivity was observed for all the
mutant viruses except the M114A mutant (Figure 6D). To
analyze the impact of the Q115A and Q115E mutations
on assembly in E. coli, we expressed Q115A and Q115E
CANC mutants in E. coli BL21 (DE3). TEM analysis
showed that the Q115A and Q115E CANC mutants
(Figure 6E), similar to the R14 mutant (Figure 2), failed
to assemble the mature-like tubular structure. Only
immature-like spherical or aberrant particles were ob-
served (Figure 6E). To test our model supposing that
increased conformation flexibility of the β-hairpin re-
sults in alternative cleavage, we compared the pattern
of products generated by the in vitro cleavage of R14K
CA-NTD mutant protein with that of WT CA-NTD
protein (Figure 6F, G). Samples of purified R14K and
WT CA-NTD proteins were incubated with M-PMV
protease and cleavage products were separated by
SDS-PAGE gel and either stained by Coomassie blue
(6 F) or transblotted and developed immunochemically
using anti-M-PMV CA antibody (Figure 6G). A cleavage
product of R14K CA-NTD proteins with an estimated
molecular weight 8 kDa was observed after the 4 h incu-
bation of the sample with M-PMV protease. Protein se-
quencing confirmed the N-terminus of the 8 kDa cleavage
product (IVESV) to be identical to that of the p20 protein
in the virus particles carrying R14 and A4Hel5 mutations.
In contrast to the R14K CA-NTD protein, WT CA-NTD
Figure 4 (See legend on next page.)
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Figure 4 Transmission electron microscopy images of HEK 293 T cells expressing WT and mutant M-PMV CA-NTD. At 48 h post-transfection
of HEK 293 T cells with WT or mutant proviral vector, the cells were fixed in glutaraldehyde and postfixed in 1% osmium tetroxide. The sections were
contrasted with uranyl acetate and lead citrate and analyzed using a JEOL JEM-1200EX analytical transmission electron microscope: (A) Immature
particles assembled within the cells. (B) Mature viruses released from the cells. Bars: 100 nm.
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uct was visible on western blot.
These results strengthened our hypothesis that impair-
ment of the β-hairpin–helix 5 stabilizing interactions
leads to an increase in β-hairpin flexibility, resulting in
relocation of helix 1, which causes exposure of a novel
CA cleavage site. Therefore, we analyzed the backbone
solvent accessibility by measuring the hydrogen-deuterium
exchange rate for R14K and WT CA-NTD (Figure 7). The
CA-NTD residues were grouped according to the relative
exchange rates of their amide protons. The first group ex-
changed amide protons prior to measurement (Figure 7,
black color), the second group exchanged protons with a
relative rate comparable for both WT and R14K (Figure 7,
green color), and the third group exchanged protons at a
relatively higher rate for R14K than WT (Figure 7, red
color). Residues with altered exchange rates were all
situated in the proximity of helices 1, 2, and 5, thus
supporting the hypothesis that these areas have different
degrees of flexibility in WTand R14K.
Discussion
The transition from an immature to mature lattice is
controlled by changes in the CA structure. Based onFigure 5 Relative infectivity of M-PMV CA-NTD mutants
determined by single-round assay. HEK 293 T cells were
co-transfected with WT or mutant pSARM-EGFP and pTMO vectors.
At 48 h post-transfection, viruses were filtered from culture media
and normalized by quantitative Western blotting for CA. Equivalent
amounts of viruses were used to infect fresh HEK 293 T cells. At 48 h
post-infection the cells were harvested and the numbers of
GFP-positive cells were determined by flow cytometry (BD FACSaria).
The mean percentage of five independent infectivity measurements
(with calculated standard deviations) for each mutant relative to the
WT is shown.hydrogen-deuterium exchange experiments, the structural
changes that occur during HIV-1 CA maturation after
proteolytic release of its N- and C-termini are formation
of the β-hairpin, slight reorientation of helix 1, dissolution
of a 3-fold interaction involving the region around the
cyclophilin A-binding loop, and formation of the NTD-
CTD interface [14]. Release of the N-terminus of HIV-1
CA leads to formation of the β-hairpin, a structural elem-
ent critical for formation of a mature core [15]. Release of
the C-terminus of HIV-1 or RSV CA proteins and subse-
quent structural changes are the final steps of Gag matur-
ation, and they seem to be important for transition of the
immature-like lattice into the mature virus particle [25].
Interestingly, it was shown that the β-hairpin is only
created upon proteolytic cleavage of the HIV-1 CA C-
terminus at the CA-SP1 site [14]. Based on the available
mutational data, it is clear that prevention of β-hairpin
formation or its stabilization via the proline-aspartate
salt bridge are fatal for mature lattice formation of the
infectious core of HIV-1 and M-PMV [15,16,26,27]. Al-
though several functions of the β-hairpin have been
proposed, its exact role remains unclear. One potential
role of the β-hairpin is to contribute to destabilization
of the immature lattice [10-14]. This assumption is
supported by the fact that there is no evidence for dir-
ect intermolecular contacts mediated by the β-hairpin
in the HIV-1 CA mature hexamer [9]. For equine in-
fectious anemia virus (EIAV) CA, it was proposed that
the purpose of maturational folding of the β-hairpin is
to extend helix 1 at the N-terminus to enhance CA
oligomerization [1]. Our present work supports another
hypothesis – that β-hairpin formation and stabilization
serve as a mechanism restricting CA-NTD flexibility, thus
locking the CA-NTD helical bundle in its mature con-
formation [14].
Since the structure of the mature M-PMV core is not
available, we used the NMR structure of M-PMV CA-NTD
to demonstrate that the β-hairpin is additionally stabilized
by interactions with residues localized in helix 5 (residues
110–115) [6]. We designed a series of mutations to abolish
these putative stabilizing interactions. Initially, we ex-
changed four amino acids in helix 5 (111DAQMQ115)
for alanines (A4Hel5). Subsequently, residues R14 and
D111, which were proposed to form stabilizing electro-
static interactions, were exchanged for similar (R14K,
D111E), neutral (R14A, D111A), or oppositely charged
(R14E, D111N) residues. In vitro and in vivo analyses
of these mutants revealed a critical role of residue R14
Figure 6 (See legend on next page.)
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Figure 6 Impact of R14K and D111N mutations on the CA-NTD structure. (A) CCS Combined chemical shift (CCS) changes of R14K and WT
CA-NTD (blue), and D111N and WT (red). Helices 1 - 6 are annotated as h1 - h6. (B) Residues with the largest CCS caused by the R14K mutation:
green - R14; orange: T3, E4, T5, V6 in β-hairpin; blue: W52, D57 in loop connecting helices 2 and 3; yellow: Q113, M114, Q115, Y116, D117, G119,
F121, A122 in helices 5, 6, and the connecting loop. The asterisk indicates the internal cleavage site between A43 and I44 (red). The WT M-PMV
CA-NTD structure (PDB ID: 2KGF) was used for this model. (C) Western blot of CA related proteins in released WT and CA-NTD mutant M-PMV
particles detected with rabbit antibodies raised against M-PMV CA. VLPs released from the of HEK 293T cells 48 h post-transfection were centrifuged
through a 20% sucrose cushion. (D) HEK 293T cells were co-transfected with WT or mutant pSARM-EGFP and pTMO vectors. At 48 h post-transfection,
the virus was filtered from culture media and normalized by quantitative Western blotting for CA. At 48 h post-infection with equivalent amounts of
virions, the HEK 293T cells were harvested and the GFP-positive cells were counted using flow cytometry. The mean percentage of three independent
infectivity measurements for each mutant relative to WT is shown. (E) Electron micrographs of thin sections of E. coli expressing Q115A and Q115E
M-PMV CANC protein. (F, G) Coomassie blue stained (F) or western blot analysis (G) of R14K CA-NTD and WT CA-NTD proteins cleavage in vitro.
M-PMV R14K CA-NTD and WT CA-NTD purified proteins in storage buffer (lanes 1 and 4, respectively) were diluted into M-PMV protease cleavage
buffer (lanes 2 and 5). M-PMV protease was added to R14K CA-NTD (lane 3) and WT CA-NTD (lane 6) and incubated for 4 h at 37°C.
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arginine to lysine led to a complete loss of infectivity and
inability of the R14K CANC mutant to assemble into
mature-like structures in vitro. This is likely due to the
inability of R14 mutants to lock CA-NTD in β-hairpin-
stabilized mature conformation, similarly to ΔProCANC
particles, in which β-hairpin cannot be formed. Notably,
all mutations of R14 tested, as well as the A4Hel5 muta-
tion, induced formation of a novel internal cleavage siteFigure 7 Comparison of hydrogen-deuterium exchange rates
for WT and R14K CA-NTD proteins. The amide proton relative
exchange rates of individual segments of the protein backbone are
shown in different colors: black - solvent-exposed amide groups
exchanged protons prior to measurement, green - comparable relative
rate of exchange for both WT and R14K proteins, red - substantially
higher rates of exchange for the R14K mutant than for the
WT protein.within helix 2. On the other hand, the D111 mutations
did not impair the mature core assembly and did not
dramatically change the infectivity. The only exception
was the D111N mutant, which failed to assemble VLPs
in E. coli cells. Since this mutation did not influence
either infectivity or proteolytic processing in tissue
culture cells, we consider this phenotype to be a “false
negative” that can be ascribed to the somewhat artificial
in vitro assembly system.
Our results show that residue R14 and residues
112–115 in helix 5 are indispensable for formation of
mature particles. In contrast, the importance of the
electrostatic interaction of residues R14 and D111 in
the stabilization of the β-hairpin was not confirmed.
The impacts of the D111N and R14K mutations on
the structure of CA-NTD were analyzed using NMR
spectroscopy. Chemical shifts in 1H-15N HSQC spectra of
both CA-NTD mutants showed that the overall protein
fold was not affected by either mutation. Moreover, chem-
ical shift differences between the D111N mutant and WT
and comparison of 15N-NOESY spectra showed that the
structural changes caused by the mutation are negligible.
In contrast, the 1H-15N HSQC spectrum of the R14K CA-
NTD mutant showed more profound changes in chemical
shifts compared to the WT. The most dramatic changes
were found in both the β-hairpin and helix 5. Mutational
analyses showed that the phenotypes of viruses in which
the residues most affected by R14 mutation were mutated
(i.e., E4A, H16A, W52A, Q115A, Q115E, and Y116A)
were similar to that of the R14K mutant, i.e., CA-NTD
was internally cleaved and the viruses were less infectious.
Similar to R14K CANC, the Q115A and Q115E CANC
mutant proteins also failed to assemble into tubular-like
mature structures in E. coli. We hypothesize that these
mutations disrupted the network of interactions stabilizing
the β-hairpin. This subsequently increased the flexibility
of helix 1, thus exposing a new cleavage site for M-PMV
protease (Figure 6B).
Hydrogen-deuterium (H/D) exchange monitored by mass
spectroscopy experiments showed that the transition from
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panied by increased protection against H/D exchange
due to decreased flexibility in helix 1 and the β-hairpin
[14]. This data is in good agreement with our H/D ex-
change results, which show the same shift in H/D protec-
tion pattern when comparing R14K, a CA-NTD mutant
destabilizing the β-hairpin and helix 5 interactions, with
WT CA-NTD. Taken together, our observations support a
model in which the main importance of the β-hairpin for
mature assembly lies in maintaining tight packing of
helices 1–3, facilitating central 18-helix bundle formation
in mature particles. We show that in M-PMV CA this
packing effect is mediated not only by β-hairpin formation
itself, but also by its interaction with helix 5.
Conclusions
Upon maturation, the N-terminus of retroviral CA folds
to form a β-hairpin, which is primarily stabilized by a
salt bridge between the N-terminal proline and a highly
conserved aspartate residue. Combining functional and
structural analyses, we identified a network of supportive
interactions stabilizing the N-terminal β-hairpin in mature
M-PMV CA-NTD. This network comprises residues in
the β-hairpin, the loop connecting helices 2 and 3, and
helix 5. Mutations of these residues most probably lead to
an increase in β-hairpin flexibility and exposure of a novel
CA cleavage site. Subsequently, despite the presence of
certain level of the full-length CA, the concurrent oc-
currence of N-terminally truncated CA (p20) protein
interferes with the formation of a mature core and this
dominant-negative effect results in formation of aberrant
core hampering the infectivity of the mutant virus. In sum-
mary, we show that in addition to the salt bridge between
the N-terminal proline and aspartate 57, other β-hairpin-
stabilizing interactions in M-PMV CA-NTD are essential
for the virus infectivity.
Methods
Cloning
All DNA manipulations were carried out using standard
subcloning techniques, and plasmids were propagated in
E. coli DH5α. All newly created constructs were verified
by DNA sequencing. To introduce point mutations within
CA of a proviral M-PMV DNA vector (pSARM4), we
initially used a helper vector prepared by ligation of a
SacI-Eco72I fragment corresponding to nucleotides 1165
to 3275 of M-PMV into pUC19 (MHelppUC19) [23]. CA
point mutations were created by PCR mutagenesis using
primers carrying appropriate mutations (A4Hel5, R14A,
R14K, R14E, D111A, D111N, D111E, E4A, H16A, W52A,
M114A, Q115A, Q115E, Y116A) and suitable restriction
endonuclease sites (StuI for R14A/K/E; XmaI for D111A/
N/E and A4Hel5; SalI for E4A; KasI for H16A; MluI for
W52A; XmaI for M114A, Q115A/E, and Y116A). Theresulting PCR fragments were digested with the ap-
propriate restriction endonucleases and ligated into
MHelppUC19 cleaved with SacI and Eco72I. Following
sequence verification, the SacI-Eco72I fragment of
MHelppUC19 was ligated into pSARM4 (kindly provided
by E. Hunter). For single-round infectivity assays, the
SacI-Eco72I fragment of MHelppUC19 was ligated into
the pSARM-EGFP vector, in which enhanced green fluor-
escent protein (EGFP) replaces the env gene [28] (kindly
provided by E. Hunter). To prepare vectors for expression
of M-PMV CA-NTD or CANC proteins with A4Hel5,
R14, D111, and Q115 mutations, the NdeI-XhoI fragments
encoding CA-NTD or CANC, respectively, obtained by
PCR using pSARM4 with the appropriate mutation as a
template, were ligated into pET22b cleaved with NdeI and
XhoI. Further details of the cloning strategy and full se-
quences of all PCR primers can be obtained from the
authors upon request.
Cell growth and virus production
HEK 293 T cells were grown in Dulbecco’s modified Eagle
medium (DMEM, PAA Laboratories, Linz, Austria) sup-
plemented with 10% fetal bovine serum (PAA) and 1%
L-glutamine (PAA). Typically, HEK 293 T cells were
plated at a density of 3 × 105 cells/ml one day before
transfection and then transfected with WT or mutant
proviral DNA using X-tremeGENE DNA transfection
reagent (Roche Molecular Biochemicals) according to the
manufacturer’s instructions. Supernatants were harvested
48 h post-transfection, filtered through a 0.45 μm filter,
and centrifuged through a 20% sucrose cushion for 1 h at
200,000 × g in a Beckman SW41Ti rotor.
Protein expression, radioactive labeling, and
quantification of particle release
HEK 293 T cells transfected with appropriate DNA were
grown for 48 h post-transfection, starved for 30 min in
methionine- and cysteine-deficient DMEM (Sigma), and
pulse-labeled for 30 min with 125 μCi/ml of Tran35Slabel
(M.G.P., Czech Republic). The labeled cells were then
chased in complete DMEM for 4 h. Cells from pulse and
pulse-chase experiments were washed with phosphate-
buffered saline (PBS), lysed in 1 ml of lysis buffer A (1%
Triton X-100, 1% sodium deoxycholate, 0.05 M NaCl,
25 mM Tris, pH 8.0) on ice for 30 min and clarified by
centrifugation at 13,000 × g for 1 min. The culture
medium of the chased cells was filtered through a 0.45 μm
filter, and SDS was added to a final concentration of 0.1%.
Viral proteins were immunoprecipitated from the cells
and culture media with a polyclonal rabbit anti-M-PMV
CA antibody and separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE). Radi-
olabeled proteins were visualized on a Typhoon Phos-
phorimager. To measure particle release, the radiolabeled
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pulse-chase-labeled virion-associated CA proteins were
quantified using ImageQuant TL (Amersham Biosciences).
The released viral proteins were pelleted through a 20% su-
crose gradient at 40,000 rpm in a Beckman SW41Ti rotor
for 1 h. The virus release is shown as the relative concen-
tration of CA correlated to the level of intracellular Gag in
individual samples.
Western blotting
HEK 293 T cells were transfected with WT or mutant
proviral constructs. Virions from culture supernatants
were harvested 48 h post-transfection as described above.
The cells were washed with PBS and resuspended in 2 ×
SDS protein loading buffer (PLB). The cultivation media
were filtered through a 0.45 μm filter and centrifuged at
40,000 rpm in a Beckman SW41Ti rotor for 1 h. Cell- and
particle-associated viral proteins were separated by SDS-
PAGE, blotted onto a nitrocellulose membrane, and de-
tected with polyclonal antibodies against M-PMV CA.
Quantitative Western blotting
Virion quantification was carried out as previously de-
scribed [23]. Briefly, the amount of M-PMV CA protein
in individual viral samples was determined by comparing
the CA protein band intensities with a standard curve
prepared using purified M-PMV CA [29]. Samples of
particles released into the cultivation media, obtained
as described above, were separated by SDS-PAGE,
transferred onto a nitrocellulose membrane, probed
with appropriate antibodies, and developed using West
Femto Chemiluminescent Substrate (Thermo Scientific)
and a LAS-2000 imager. Protein band densities were quan-
tified using ImageQuant TL (Amersham Biosciences).
Single-round infectivity assay
Infectivities of WT M-PMV and the mutants were de-
termined as described [23,30]. Briefly, HEK 293 T cells
were co-transfected with WT or mutant pSARM-EGFP
expression vector [28] and the glycoprotein expression
vector pTMO [24]. At 48 h post-transfection, culture
supernatants were collected and filtered through a 0.45 μm
filter. Each sample was normalized for CA protein content
by quantitative Western blotting. The volume of culture
supernatant used to infect the HEK 293 T cells was ad-
justed such that equivalent amounts of virus were added to
each sample, and the cells were incubated for an additional
48 h. The cells were then fixed with 4% formaldehyde, and
the number of GFP-positive cells was determined using
flow cytometry (BD FACSaria).
Electron microscopy of bacterial and tissue culture cells
For thin-section electron microscopic (TEM) analysis of
the assembly of M-PMV CANC in E. coli or WT ormutant M-PMV in HEK 293 T cells, visible pellets of
cells expressing appropriate proteins were prefixed with
freshly prepared 2.5% glutaraldehyde in 0.1 M cacodylate
buffer, pH 7.5. After washing with 0.1 M cacodylate buffer,
pH 7.5, the cells were postfixed in 1% osmium tetroxide,
dehydrated in an ethanol series (30, 50, 70, 80, 90, and
100%), and embedded in fresh EMBED 812 or AGAR 100
epoxy resin. Ultrathin sections (70 nm) of cells were
contrasted with uranyl acetate and lead citrate. A JEOL
JEM-1200EX analytical transmission electron micro-
scope operated at 60 kV was used for the analysis.
Bacterial expression
Luria-Bertani medium containing 100 μg/ml ampicillin
was inoculated with E. coli BL21 (DE3) cells carrying the
appropriate construct. At an optical density at 590 nm
of 0.8, expression was induced by the addition of
isopropyl-B-D-thiogalactopyranoside (IPTG) to a final
concentration of 0.4 mM. The cells were harvested 4 h
post-induction.
Protein purification for NMR spectroscopy
R14K and D111N CA-NTD1–140 were expressed and
purified as previously described [6,31]. Briefly, the pro-
teins were overexpressed in E. coli BL21 (DE3) and
purified under native conditions by gel chromatography.
To achieve 13C and 15N isotopic enrichment, the trans-
formed bacterial cells were grown in M9 minimal medium
supplemented with D-[U-13C]-glucose and [U-15N]-NH4Cl.
The uniformly 13C, 15N-labeled CA-NTD1–140 sample for
NMR spectroscopy was prepared in 50 mM Tris buffer,
pH 8.0, containing 150 mM NaCl, 1 mM EDTA, 1 mM
TCEP, and 5% deuterium oxide. The sample was concen-
trated to 1.0 mM in a volume of 500 μl.
NMR spectroscopy
All NMR experiments were conducted at 298 K. A set of
15N-edited and 13C-edited NOESY spectra [32] of the
D111N mutant of [13C; 15N]-CA-NTD1–140 was recorded
on a Bruker Avance I 900 MHz spectrometer equipped
with a 5 mm cryogenic 1H/13C/15N TXI probe head, and
the HCCH-TOCSY spectrum [33] was recorded on a
Bruker Avance I 700 MHz spectrometer equipped with
a 5 mm cryogenic 1H/13C/15N TXI probe head. A set
of standard 3D triple-resonance HNCA, HN(CO)CA,
HNCACB, CBCA(CO)NH, and HNCO experiments
[33], as well as all other experiments, were collected on a
Bruker Avance III 600 MHz spectrometer equipped with a
5 mm cryogenic 1H/13C/15N TXI probe head.
All spectra were processed using the spectral processing
and analysis program NMRPipe/NMR-Draw 3.0 [34] and
analyzed using the graphical NMR assignment and inte-
gration software Sparky 3.111 (T. D. Goddard and D. G.
Kneller, University of California, San Francisco, USA).
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Hydrogen-deuterium exchange was monitored by NMR
spectroscopy as a decrease in signal intensity in 15N-1H
HSQC spectra. A sample of 1 mM [13C; 15N]-CA-
NTD1–140 (500 μl) dissolved in H2O was freeze-dried.
The freeze-dried sample was dissolved in [99.9% 2H]-
H2O, and the first experiment was started within
15 min after dissolution. The measurement time of a
single spectrum was 10 min. A series of spectra was
recorded until the intensities ceased to change. To
compare the exchange rates of WT and the R14K mutant,
the intensity of the signals was normalized to the intensity
of the signals of un-exchanged amide protons.
In vitro cleavage
Cleavage of CA-NTD protein with M-PMV protease was
performed as described previously [35]. Briefly, M-PMV
R14K CA-NTD and WT CA-NTD purified proteins in
storage buffer (50 mM Tris buffer, pH 8.0, 150 mM NaCl,
1 mM EDTA, 1 mM TCEP) were diluted with 50 mM
phosphate buffer, pH 6.2, containing 300 mM NaCl and
0.01% 2-mercaptoethanol to a final concentration of
0.5 mg/ml. M-PMV protease (13 kDa form) was added
to the reaction at the final concentration of 2 μM and
incubation was carried out for 4 h at 37°C. The protein
samples were then separated using SDS/PAGE gels and
stained by Coomassie blue or transblotted onto a nitro-
cellulose membrane and developed immunochemically
using polyclonal rabbit anti-M-PMV CA antibody.
Additional file
Additional file 1: Figure S1. Superimposed 1H-15N HSQC spectra of WT
(red), D111N (blue), and R14K (green) CA-NTD proteins. (A) Backbone
resonances of the respective proteins are labeled. Side-chain resonances
are not labeled and backbone resonances in the framed central part of
the spectrum are labeled only in (B) for the reason of clarity. The residues
of D111N and R14K mutants with largest combined chemical shift
changes are underlined.
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